Icahn School Of Medicine At Mount Sinai
Clinical trials sponsored by Icahn School Of Medicine At Mount Sinai, explained in plain language.
-
Zapping the ear to wake the brain: new hope for coma patients
Disease control Recruiting nowThis study is testing whether a combination of two therapies can help patients with severe, long-term brain injuries regain consciousness and function. Fifteen participants will receive gentle electrical stimulation to the ear (vagus nerve stimulation) while using a robotic table…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Virtual reality breakthrough tested for debilitating 'Land Sickness'
Disease control Recruiting nowThis study aims to improve treatment options for Mal de Débarquement Syndrome (MdDS), a balance disorder that causes persistent rocking, swaying, or pulling sensations. Researchers are testing whether virtual reality goggles can make an existing therapy more accessible, and wheth…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill trial targets troubling skin and scalp conditions in down syndrome
Disease control Recruiting nowThis study is testing if a daily pill called Abrocitinib can help control eczema (atopic dermatitis) and patchy hair loss (alopecia areata) in people with Down Syndrome. It will enroll 56 participants aged 12 and older. The goal is to see if the treatment is safe and effective at…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Nerve-Zapping device aims to rewire Stroke-Damaged brains
Disease control Recruiting nowThis study is creating a registry to monitor the safety and effectiveness of a surgically implanted device that stimulates the vagus nerve to help people recover movement after a stroke. It will follow 40 adults with chronic stroke who are getting the device as part of their stan…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New gut therapy challenges standard stool transplants for dangerous infections
Disease control Recruiting nowThis study is testing a new, standardized microbial therapy called MTC01 against the current standard treatment, a fecal microbiota transplant (FMT), for people who keep getting repeat C. diff infections. It aims to see if the new treatment is as safe and effective as the stool t…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial offers hope for Tough-to-Treat blood cancer patients
Disease control Recruiting nowThis study is testing whether an oral medication called reparixin can help control advanced myelofibrosis, a serious bone marrow cancer. It's for patients whose disease has worsened despite standard treatments or who cannot take those treatments. Researchers will measure if the d…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for kids with hair loss: drug trial aims to regrow scalp hair
Disease control Recruiting nowThis study is testing whether a medication called dupilumab can help regrow hair in children and teenagers with moderate-to-severe alopecia areata, an autoimmune condition that causes hair loss. About 76 participants, aged 6 to 18, will receive either the drug or a placebo via in…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists test 'Mind-Reading' helmet to stop binge eating
Disease control Recruiting nowThis study is testing whether giving women with bulimia nervosa real-time feedback about their brain activity while they eat can help them gain better control over their eating behaviors. Researchers will use a special wearable brain-scanning device during a single training sessi…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New Triple-Therapy trial aims to shrink liver tumors for transplant
Disease control Recruiting nowThis study is testing whether a three-part treatment can help people with liver cancer become eligible for a liver transplant. It combines a targeted radiation treatment (Y-90) with two drugs (atezolizumab and bevacizumab) to try to shrink or control tumors. The goal is to either…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
CBD tested as potential Game-Changer in fight against opioid addiction
Disease control Recruiting nowThis study is testing whether cannabidiol (CBD), a non-intoxicating compound from cannabis, can help people with opioid addiction stay off illicit drugs. It will involve 450 adults who are already receiving standard medication treatment (methadone or buprenorphine). Participants …
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Could morning light help calm a troubled gut?
Disease control Recruiting nowThis small pilot study is testing whether morning light therapy can help reduce inflammation and improve symptoms in adults with ulcerative colitis who also have poor sleep. Participants will use a wearable device to track sleep and receive one hour of morning light therapy daily…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test mind training to tame emotional storms in borderline patients
Disease control Recruiting nowThis study is testing a new training program that teaches people with borderline personality disorder (BPD) how to better manage their intense emotions. Researchers will work with 130 participants to see if learning specific thinking strategies can change brain activity and reduc…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Kidney stone prevention: simple approach vs. customized testing
Disease control Recruiting nowThis study compares two methods to prevent calcium oxalate kidney stones from returning after surgery. 80 patients at Mount Sinai West will be randomly assigned to receive either standard prevention treatment or personalized treatment based on detailed urine testing. Researchers …
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Could HIV drugs be the key to taming long covid?
Disease control Recruiting nowThis study is testing whether two existing HIV antiviral medications can help reduce the burden of symptoms for people living with Long Covid. Researchers will compare the drugs, taken daily for 90 days, against a placebo pill in 90 adult participants. The main goal is to see if …
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Simple rinse could cut Post-Surgery infections for bladder cancer patients
Disease control Recruiting nowThis study is testing if rinsing the bowel segment used to create a new urine system with a common antiseptic (chlorhexidine) during and after bladder removal surgery can prevent infections. The goal is to see if this rinse helps keep the urine sterile and reduces the number of p…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Could an earthworm enzyme ease the burden of long covid and chronic fatigue?
Disease control Recruiting nowThis early-stage study is testing whether a supplement called lumbrokinase can improve overall health and reduce symptoms for people with three debilitating long-term conditions: Long Covid, chronic Lyme disease, and ME/CFS (chronic fatigue syndrome). The trial will enroll 120 ad…
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Mind over gut: new trial combines therapy with drugs for Crohn's disease
Disease control Recruiting nowThis study is testing whether adding a psychological resilience program to standard biologic medication helps people with Crohn's disease achieve better long-term results. It will enroll 170 adults newly starting a biologic drug who have active Crohn's symptoms. The goal is to se…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New diet approach aims to stop anorexia relapse
Disease control Recruiting nowThis study is testing whether a special eating plan called the Metabolic Diet can help women who have recovered from anorexia nervosa maintain their healthy weight and avoid relapse. The diet focuses on higher fat and lower carbohydrate foods to help keep blood sugar levels stabl…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New Triple-Threat attack on aggressive prostate cancer before surgery
Disease control Recruiting nowThis study is testing a combination of three drugs given before surgery (prostate removal) for men with high-risk prostate cancer. The goal is to see if this treatment can shrink the tumor so much that very little cancer is left after surgery. The study will enroll 40 men whose c…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New Two-Drug attack on recurrent Women's cancers
Disease control Recruiting nowThis study aims to find the safest and most effective dose of a new drug, sacituzumab govitecan, when combined with an existing chemotherapy drug, cisplatin. It is for women whose ovarian or endometrial cancer has returned but responded well to platinum-based chemotherapy in the …
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
Zapping the brain to fight cocaine addiction
Disease control Recruiting nowThis study is testing whether a combination of gentle brain stimulation and mental training can help people with cocaine addiction reduce their cravings. Researchers will enroll 120 adults with cocaine use disorder to receive either real or fake stimulation while practicing techn…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Virtual lifeline: can online therapy stop psychosis before it starts?
Disease control Recruiting nowThis study is testing whether therapy delivered through video calls can help teens and young adults who show early warning signs of psychosis. Researchers want to see if online group, family, or individual therapy can reduce symptoms, improve daily functioning, and possibly preve…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Heart surgery side effect: major trial tests if blood thinners prevent strokes
Disease control Recruiting nowThis study aims to find out if adding a blood-thinning pill helps prevent strokes and other blood clots in patients who develop a temporary irregular heartbeat after coronary artery bypass surgery. It will compare the benefits of preventing clots against the risk of serious bleed…
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New pill trial aims to tame stubborn, painful scars
Disease control Recruiting nowThis study is testing whether a daily pill called ritlecitinib can help people with keloids—thick, raised scars that can be painful and itchy. The trial will see if the drug can prevent keloids from coming back after surgery and reduce symptoms in people who don't have surgery. A…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Can a mediterranean diet slow down MS? new trial investigates
Disease control Recruiting nowThis study is testing whether following a specific brain-healthy diet, called the MIND diet, can help protect the brain and manage symptoms in people with multiple sclerosis (MS). 100 adults with MS will be randomly assigned to either follow the MIND diet for a year or continue t…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Extra support for families fighting eating disorders
Disease control Recruiting nowThis study is testing if adding a peer coach to standard therapy helps teens with eating disorders and their parents. For 12 weeks, families will get either coaching for the teen or the parent, plus educational materials for the other. Researchers want to see if this extra suppor…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Old arthritis drug could offer new hope for rare blood cancers
Disease control Recruiting nowThis study is testing whether adding a low-dose, inexpensive drug called methotrexate helps people with certain rare blood cancers. Researchers want to see if it safely reduces symptoms like enlarged spleen, fatigue, and abnormal blood cell counts when added to a patient's curren…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New drug trial aims to tame stubborn lupus
Disease control Recruiting nowThis is an early-stage study to see if a new drug called alnuctamab is safe and might help control lupus in people whose disease hasn't improved with standard treatments. The drug works by guiding the body's own immune cells to attack the harmful cells thought to drive lupus. The…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for stubborn psoriasis: drug tested when other treatments fail
Disease control Recruiting nowThis study is testing whether the drug bimekizumab can help people with moderate-to-severe plaque psoriasis when other similar medications have not worked. It will involve 60 adults who previously tried and did not respond well to treatments targeting IL-17 or IL-23. Participants…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
New brain drain device tested for Life-Threatening bleeds
Disease control Recruiting nowThis study is testing a new, FDA-approved brain catheter system designed to drain fluid and blood from the brain after a severe bleed. It aims to see if this new system can clear blood faster and more safely than the standard catheters currently used. The research will involve 17…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Nerve pill trial aims to tame HIV-Related gut troubles
Disease control Recruiting nowThis study is investigating whether problems with the vagus nerve contribute to gut issues and inflammation in people living with HIV. Researchers will test if a medication called pyridostigmine or gentle nerve stimulation can help. The goal is to find new ways to manage these co…
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Home coaches aim to keep COPD patients out of hospitals
Disease control Recruiting nowThis study is testing a home-based coaching program to help adults with COPD better manage their condition. Health coaches will work with 300 participants, primarily from minority and low-income communities in New York City, to improve medication use, exercise, and spot early sig…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New program aims to help 9/11 responders breathe easier
Disease control Recruiting nowThis study is testing a self-management program designed to help World Trade Center responders better control their asthma. The program teaches participants how to properly use their inhalers and manage their symptoms. Researchers will measure whether the program improves asthma …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC
-
Ear bud for seizures: new device aims to replace uncomfortable brain tests
Diagnosis Recruiting nowThis study is testing a new in-ear device called SeizEAR to see if it can safely and effectively monitor brain waves and detect seizures in people with epilepsy. Researchers will compare the device's readings to the standard method, which involves placing many electrodes on a per…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Could a tiny sensor replace the diabetes lab test for pregnant women?
Diagnosis Recruiting nowThis study is testing if a small, wearable continuous glucose monitor (CGM) can be used to diagnose gestational diabetes. It will compare the CGM's readings to the standard glucose lab test in 150 pregnant women. The goal is to see if the simpler, wearable device is as accurate a…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
Could a sip of water replace complex swallow tests?
Diagnosis Recruiting nowThis study is testing whether a simple 3 oz water sip test can safely screen for swallowing problems in patients with tracheostomy tubes. Researchers will compare this quick bedside test to the current, more complex gold-standard swallowing exams. The goal is to find a faster, ea…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
Sit-Down scans could revolutionize prostate cancer detection
Diagnosis Recruiting nowThis study is testing whether a new, more comfortable upright MRI scanner works as well as the standard enclosed MRI for detecting prostate cancer. Researchers will compare both types of scans in 550 men at risk for prostate cancer over about 5 years. The goal is to see if the up…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
New scanner aims to slash prostate surgery time
Diagnosis Recruiting nowThis study is testing a new, FDA-approved imaging device called the Histolog Scanner. It is used during prostate cancer surgery to quickly check if cancer cells are left at the edges of the removed tissue. The main goal is to see if this scanner can save surgeons at least 20 minu…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
Could a simple sensor replace the dreaded Post-Baby sugar test?
Diagnosis Recruiting nowThis study aims to see if data from a continuous glucose monitor worn during late pregnancy and after birth can predict who will have abnormal blood sugar results on the standard postpartum test. It involves 40 women who had gestational diabetes and are already using a specific g…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC
-
New scan aims to spot hidden prostate cancer sooner
Diagnosis Recruiting nowThis study is testing whether a new type of PET scan can find aggressive prostate cancer better than the standard MRI scan in men who are being monitored instead of immediately treated. About 120 men with low-risk prostate cancer on active surveillance will get both the new PET s…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Mar 09, 2026 14:24 UTC
-
Race against time: which test finds cancer faster?
Diagnosis Recruiting nowThis study compares two standard procedures used to diagnose cancer when fluid builds up around the lungs. Researchers want to know if starting with a more invasive biopsy (pleuroscopy) leads to a faster diagnosis and quicker start of cancer treatment compared to starting with a …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Feb 24, 2026 14:06 UTC
-
New hope for female veterans struggling with trauma and brain injury
Symptom relief Recruiting nowThis study is testing two different therapy programs to help female veterans who have experienced military sexual trauma or intimate partner violence, and who also have a history of brain injury. Researchers want to see which approach works better at helping participants manage t…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Apr 01, 2026 19:56 UTC
-
New shot tested to make uterine exams less painful
Symptom relief Recruiting nowThis study is testing if adding an anti-inflammatory drug (ketorolac) to the standard numbing shot (lidocaine) can better reduce pain for women undergoing a common uterine exam called hysteroscopy. It will compare the new combination shot to the standard shot alone in 60 women. T…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
New program aims to bridge care gap for women of color with advanced breast cancer
Symptom relief Recruiting nowThis pilot study is testing whether a community navigator can help Black and Latina women with metastatic breast cancer better access supportive care services. Participants will work with a trained navigator who helps connect them to resources and provides education. The study ai…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Zap and move: new device aims to boost therapy for teens with cerebral palsy
Symptom relief Recruiting nowThis study is testing the safety and feasibility of a non-invasive device that gently stimulates a nerve in the neck while teens with cerebral palsy do hand therapy. The goal is to see if this combination can help improve hand and arm function. The study will enroll about 10 adol…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Better C-Section pain relief? study tests two spinal additives
Symptom relief Recruiting nowThis study compares two medications (epinephrine and dexmedetomidine) when added to spinal anesthesia during planned cesarean sections. Researchers want to see if one provides longer-lasting pain relief without more side effects. The trial involves 62 pregnant patients having sch…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
VR hypnosis trial offers new hope for HIV pain relief
Symptom relief Recruiting nowThis study is testing whether self-hypnosis software used with a virtual reality headset can help reduce chronic pain in people living with HIV. Researchers will enroll 25 adults with HIV who have experienced chronic pain for at least 90 days. The study will check if the software…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 27, 2026 12:41 UTC
-
Can your FitBit help tame your irregular heartbeat?
Symptom relief Recruiting nowThis study is testing if a personalized exercise program, guided by a FitBit and digital health tools, can help people with a common heart rhythm problem called atrial fibrillation (AFib) feel better. Researchers will enroll 120 adults with symptomatic AFib to see if this tech-su…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Could a drug that calms inflammation help restore joy in depression?
Symptom relief Recruiting nowThis study is testing whether a drug that blocks a specific immune signal (IL-6) can help improve the brain's reward system and reduce the loss of pleasure in adults with major depression. Up to 20 participants with depression and signs of immune system activation will receive th…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
NYC launches 'Hope' workshops to fight health worker burnout
Symptom relief Recruiting nowThis study is testing a program designed to reduce stress and burnout for community health workers in New York City. About 168 workers will attend six online workshops over six months, learning skills like coping with fear and building social support. Researchers will measure cha…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
Glasses that fight pain? new device trial for lyme sufferers
Symptom relief Recruiting nowThis study is testing a new, non-drug device called the Sana Pain Reliever to see if it can reduce chronic pain in people with Post-treatment Lyme Disease. The device is a special mask with earbuds that pulses light and plays tones for 15-minute sessions at home. Researchers will…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 25, 2026 14:07 UTC
-
Can ballet classes help kids with autism move and feel better?
Symptom relief Recruiting nowThis study is testing if a 12-week recreational ballet program can help children with autism. Researchers want to see if weekly dance classes improve motor skills, behavior, and mood. The study will enroll 32 children, ages 6 to 12, who have an autism diagnosis.
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
Can music and group recitals help kids fight depression?
Symptom relief Recruiting nowThis study is testing whether music therapy can help children with depression. Twenty children will receive 11 weekly music therapy sessions. Half of the group will also attend special recitals to observe performers and discuss how sharing creativity affects their feelings and re…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC
-
Ear stimulation trial aims to ease eating for teens with anorexia
Symptom relief Recruiting nowThis study is testing if a gentle, non-invasive device that stimulates a nerve in the ear can help teens with anorexia nervosa during their refeeding treatment. Over 4 weeks, researchers will compare the real stimulation to a fake (sham) version to see if it helps participants fe…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 17, 2026 13:09 UTC
-
Cultural memory help: new study aims to support chinese american seniors
Symptom relief Recruiting nowThis study is testing whether a proven memory support system can be helpful for older Chinese Americans who have mild thinking and memory problems. Researchers are adapting the program for Mandarin and Cantonese speakers to see if it improves daily life and memory skills. The stu…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 16, 2026 15:26 UTC
-
Zapping the brain to quiet rage from everyday sounds
Symptom relief Recruiting nowThis study is testing whether magnetic stimulation of the brain can help people with misophonia, a condition where specific sounds cause intense irritation or anger. Researchers will use a non-invasive device to stimulate the parietal area of the brain in 60 participants. They wi…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 13, 2026 15:06 UTC
-
New nerve block could cut pain meds after heart surgery
Symptom relief Recruiting nowThis study is testing if a specific nerve block, given after heart surgery, can help control pain better. Researchers want to see if it reduces the need for strong opioid painkillers and lowers patients' pain scores. The study will involve 75 adults having planned heart surgery, …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 13, 2026 15:05 UTC
-
Cannabis-Based drug trial offers new hope for sickle cell pain
Symptom relief Recruiting nowThis study is testing whether dronabinol, a medication derived from cannabis, can help reduce chronic pain and inflammation in adults with sickle cell disease. Researchers will compare dronabinol to a placebo (inactive pill) in 60 participants to see if it improves pain levels an…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 12, 2026 13:51 UTC
-
Home care program aims to ease Dementia's final stages
Symptom relief Recruiting nowThis study is testing whether a new home-based palliative care program can improve comfort and quality of life for people with advanced dementia and reduce stress for their family caregivers. Researchers will compare the program to usual care for 300 patient-caregiver pairs in Ne…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 04, 2026 15:30 UTC
-
Pregnancy & antipsychotics: tracking mother & baby health
Knowledge-focused Recruiting nowThis study aims to understand how antipsychotic medications affect pregnant women with serious mental illness and their babies. Researchers will follow 200 pregnant women who are either taking antipsychotics, other psychiatric medications, or no medication. They'll track the moth…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Apr 01, 2026 19:56 UTC
-
Scientists probe CBD's brain effects on stress
Knowledge-focused Recruiting nowThis study aims to understand how cannabidiol (CBD) affects the brain and body's response to stress. Researchers will examine 160 young adults who experienced childhood adversity, giving them either CBD or a placebo. The study measures brain activity, stress hormones, and anxiety…
Phase: PHASE1, PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Scientists map Cancer's genetic blueprint in search of better treatments
Knowledge-focused Recruiting nowThis study aims to better understand multiple myeloma by analyzing the genetic makeup of tumors from 100 patients over two years. Researchers will use advanced sequencing techniques on blood and tumor samples collected during standard care procedures to identify genetic patterns …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists hunt for hidden environmental triggers of thyroid cancer
Knowledge-focused Recruiting nowThis study aims to understand how environmental exposures, like certain chemicals, might affect thyroid cancer risk and how aggressive it becomes. Researchers will enroll 500 adults with thyroid nodules who are scheduled for surgery. They will collect small blood samples and use …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Can flashing lights boost your brain?
Knowledge-focused Recruiting nowThis study is testing whether looking at rhythmic, flashing lights can improve brain activity and memory in people with mild cognitive impairment. Twenty participants will have their brain waves measured while they watch different light patterns. The goal is to see if the lights …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists monitor transplant Patients' blood sugar to predict recovery
Knowledge-focused Recruiting nowThis study aims to understand how blood sugar levels after a liver transplant affect a patient's recovery and the long-term success of the transplant. Researchers will have 40 recent liver transplant patients wear a small, hidden glucose monitor for 30 days after leaving the hosp…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt plastic clues in our guts
Knowledge-focused Recruiting nowThis study aims to understand if tiny plastic particles in our environment affect gut bacteria and inflammation, potentially increasing the risk for Crohn's disease and other bowel conditions. Researchers will analyze stool samples from pregnant women with Crohn's, healthy women,…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Scientists seek genetic clues to mysterious artery diseases
Knowledge-focused Recruiting nowThis research study aims to understand the biological and genetic causes of fibromuscular dysplasia (FMD) and two related artery conditions. Researchers will collect blood and tissue samples from 600 people with these conditions and healthy volunteers. By comparing these samples,…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists scan brains to crack code of Binge-Eating cycles
Knowledge-focused Recruiting nowThis study aims to understand how eating and fasting affect brain function related to self-control in people with bulimia nervosa. Researchers will use brain scans and smartphone surveys to see how the brain's control circuits work differently after a meal. The goal is to learn w…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Antibiotic trial probes Gut's role in MS brain inflammation
Knowledge-focused Recruiting nowThis study aims to understand how the antibiotic vancomycin affects the community of bacteria in the gut and the immune system in people with multiple sclerosis (MS). Researchers will give vancomycin to 12 newly diagnosed, untreated MS patients and track changes in their gut bact…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test Anti-Aging cocktail for smokers
Knowledge-focused Recruiting nowThis early-stage study is testing whether a combination of exercise, a dietary supplement (spermidine), and one of two drugs (rapamycin or lamivudine) is safe and feasible for older adults who smoke or used to smoke. The main goal is to see if participants can stick to the regime…
Phase: PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Mount sinai launches major study to unlock secrets of deadly pancreatic cancer
Knowledge-focused Recruiting nowThis study is creating a large registry of people with pancreatic diseases or who are at high risk for pancreatic cancer. Researchers will collect health information and blood samples from participants to learn how family history, genetics, and other factors contribute to disease…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists probe deep brain to unlock Depression's secrets
Knowledge-focused Recruiting nowThis study aims to understand how depression changes the brain's reward system. Researchers will record brain activity from 10-24 epilepsy patients who are also being monitored for depression while they play a simple gambling game. The goal is to identify specific brain patterns …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Could loneliness be shortening lives in schizophrenia?
Knowledge-focused Recruiting nowThis study aims to understand if social isolation contributes to the poorer physical health and shorter lifespan often seen in people with schizophrenia. Researchers will follow 650 people, including 500 with schizophrenia and 150 of their siblings, to see how social connections …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Major study launched to solve mysteries of rare, painful blood disease
Knowledge-focused Recruiting nowThis study aims to track 1,500 people with rare porphyria blood disorders over many years to better understand how the diseases progress, how treatments work, and what affects patients' quality of life. Researchers will collect health information, lab results, and genetic data to…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
New brain scan tech aims to sharpen Surgeons' view during critical bleed removal
Knowledge-focused Recruiting nowThis study is testing two new types of brain scan software from Siemens to see if they are useful for surgeons. The goal is to help doctors see brain bleeds more clearly during and after a minimally invasive surgery to remove them. Researchers will collect scans from about 15 adu…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC
-
Your mammogram could also warn about heart disease
Knowledge-focused Recruiting nowThis study is testing whether telling women about a specific finding on their mammogram—calcifications in breast arteries—helps them take steps to improve their heart health. Researchers will enroll over 5,700 women to measure how common this finding is. Then, they will tell some…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC
-
Scientists feed people sugar to unlock Gut's role in diabetes risk
Knowledge-focused Recruiting nowThis study aims to understand how eating a lot of fructose (a common sugar) changes the bacteria in your gut and affects your metabolic health, including liver fat and diabetes risk. Researchers will have 30 adults who poorly absorb fructose follow two different 12-day diets—one …
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC
-
Scientists scan brains to crack the code of OCD
Knowledge-focused Recruiting nowThis study aims to better understand the brain activity and thinking patterns behind obsessive-compulsive disorder (OCD). Researchers will use brain scans (EEG) and computer models to compare 50 adults with OCD to 50 healthy adults. The goal is to gather detailed information that…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 20, 2026 15:01 UTC
-
Could your Child's skin tone affect oxygen readings? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if pulse oximeters, the clip-on devices that measure blood oxygen, are equally accurate for children with different levels of skin pigmentation. It will observe 92 pediatric patients with congenital heart disease who are already scheduled for heart s…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:41 UTC
-
Mount sinai launches major study to track biologic drug effects in immune disease patients
Knowledge-focused Recruiting nowThis study is creating a large registry of patients with immune system diseases who are receiving biologic medications as part of their standard care. Researchers will collect health information and samples from about 800 participants to better understand how these treatments wor…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:54 UTC